[Effectiveness of bisphosphonate administration for prevention of osteopenia during Gn-RH agonist therapy of endometriosis].

article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-07, 2026-07-18

This study investigated the effectiveness of bisphosphonate administration in preventing osteopenia in women undergoing GnRH agonist therapy for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bone Density Bone Density Conservation Agents Bone Diseases, Metabolic Diphosphonates Endometriosis Gonadotropin-Releasing Hormone Bone Density Conservation Agents Bone Diseases, Metabolic Bone Diseases, Metabolic Diphosphonates Drug Therapy, Combination Endometriosis Estrogens Estrogens Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Progesterone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-05T06:13:34.187606+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0 · commercial use OK